1. |
Yahata T, Banzai C, Tanaka K. Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females:a population-based study from 1983 to 2007 in Niigata. J Obstet Gynaecol Res, 2012, 38(4):645-650.
|
2. |
Morotti M, Menada MV, Gillott DJ, et al. The preoperative diagnosis of borderline ovarian tumors:a review of current literature. Arch Gynecol Obstet, 2012, 285(4):1103-1112.
|
3. |
Burger CW, Prinssen HM, Baak JP, et al. The management of borderline epithelial tumors of the ovary. Int J Gynecol Cancer, 2000, 10(3):181-197.
|
4. |
Basaran D, Salman MC, Calis P, et al. Diagnostic accuracy of intraoperative consultation (frozen section) in borderline ovarian tumours and factors associated with misdiagnosis. J Obstet Gynaecol, 2014, 34(5):429-434.
|
5. |
Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 2006, 95 Suppl 1:S161-192.
|
6. |
Wong HF, Low JJ, Chua Y, et al. Ovarian tumors of borderline malignancy:a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer, 2007, 17(2):342-349.
|
7. |
Morice P, Denschlag D, Rodolakis A, et al. Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer, 2011, 21(5):951-963.
|
8. |
Seong SJ, Kim da H, Kim MK, et al. Controversies in borderline ovarian tumors. J Gynecol Oncol, 2015, 26(4):343-349.
|
9. |
Shim SH, Kim SN, Jung PS, et al. Impact of surgical staging on prognosis in patients with borderline ovarian tumours:A metaanalysis. Eur J Cancer, 2016, 54:84-95.
|
10. |
Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol, 2002, 86(1):34-37.
|
11. |
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available at:http://www.cochranehandbook.org.
|
12. |
GA Wells SB, O. C. D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, Available at:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, [March2016].
|
13. |
Hayley AC, Downey LA, Shiferaw B, et al. Amphetamine-type stimulant use and the risk of injury or death as a result of a roadtraffic accident:A systematic review of observational studies. Eur Neuropsychopharmacol, 2016, 26(6):901-922.
|
14. |
陶陶, 曹冬焱, 杨佳欣, 等.卵巢交界性上皮性肿瘤复发相关因素及术后生育状况的分析.中华医学杂志, 2010, 90(19):1304-1308.
|
15. |
陶陶, 曹冬焱, 杨佳欣, 等.交界性卵巢上皮性肿瘤保守性手术的预后与生育状况.中国医学科学院学报, 2010, 32(5):488-492.
|
16. |
戴伟超.交界性卵巢肿瘤89例临床和病理特征及复发相关因素、术后生育状况的分析.福建医科大学, 2013.
|
17. |
高彩霞. 40岁以下卵巢上皮性交界性肿瘤患者保留生育功能63例临床分析.大连医科大学, 2012.
|
18. |
高峻, 曲立兵.卵巢交界性肿瘤的诊断与治疗.内蒙古医学院学报, 2011, (3):249-252.
|
19. |
华晓萍. 231例卵巢交界性浆液性肿瘤的临床病例分析.浙江大学, 2015.
|
20. |
李青, 赵卫东, 程敏, 等. 124例卵巢交界性肿瘤的临床分析.安徽医科大学学报, 2012, (11):1361-1364.
|
21. |
刘玉蕾.腹腔镜手术处理卵巢交界性肿瘤的预后分析.河南科技大学学报(医学版), 2011, (1):38-39.
|
22. |
秦聪颖.卵巢交界性肿瘤临床病理特征及预后相关分析.河北医科大学, 2015.
|
23. |
任婕, 楼江燕, 刘辉, 等.交界性卵巢上皮性肿瘤234例临床病理及预后分析.中华妇产科杂志, 2009, 44(2):116-120.
|
24. |
沈红雁.卵巢交界性肿瘤的临床特征及其预后相关因素研究.安徽医科大学, 2012.
|
25. |
Romagnolo C, Gadducci A, Sartori E, et al. Management of borderline ovarian tumors:results of an Italian multicenter study. Gynecol Oncol, 2006, 101(2):255-260.
|
26. |
Wu TI, Lee CL, Wu MY, et al. Prognostic factors predicting recurrence in borderline ovarian tumors. Gynecol Oncol, 2009, 114(2):237-241.
|
27. |
Maneo A, Vignali M, Chiari S, et al. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol, 2004, 94(2):387-392.
|
28. |
Desfeux P, Camatte S, Chatellier G, et al. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol, 2005, 98(3):390-395.
|
29. |
Fauvet R, Boccara J, Dufournet C, et al. Laparoscopic management of borderline ovarian tumors:results of a French multicenter study. Ann Oncol, 2005, 16(3):403-410.
|
30. |
Ødegaard E, Staff AC, Langebrekke A, et al. Surgery of borderline tumors of the ovary:retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstet Gynecol Scand, 2007, 86(5):620-626.
|
31. |
Trillsch F, Ruetzel JD, Herwig U, et al. Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT). J Ovarian Res, 2013, 6(1):48.
|
32. |
刘晓琳.交界性卵巢肿瘤的临床分析.当代医学, 2014, 20(1):58-59.
|
33. |
Furukawa N, Nishioka K, Noguchi T, et al. Port-site metastasis of mucinous borderline ovarian tumor after laparoscopy. Case Rep Oncol, 2014, 7(3):804-809.
|
34. |
Berretta R, Rolla M, Patrelli TS, et al. Incidence of port-site metastasis after laparoscopic management of borderline ovarian tumors:a series of 22 patients. Eur J Gynaecol Oncol, 2009, 30(3): 300-302.
|
35. |
Sobiczewski P, Kupryjanczyk J, Michalski W, et al. The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up. Int J Gynecol Cancer, 2016, 26(6):1053-1061.
|
36. |
Uzan C, Nikpayam M, Ribassin-Majed L, et al. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments. Ann Oncol, 2014, 25(7):1312-1319.
|
37. |
Black JD, Altwerger GH, Ratner E, et al. Management of Borderline Ovarian Tumors Based on Patient and Tumor Characteristics. Gynecol Obstet Invest, 2015 Jun 6.[Epub ahead of print].
|